Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: Novel biomarker and therapeutic target

Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: Novel biomarker and therapeutic target

Background: There remains a serious need to prevent the progression of invasive prostate cancer (PCa). We previously showed that secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a multifunctional innate immunity regulator via TLR4 ligation which has been implicated in PCa pr...

Full description

Bibliographic Details
Main Authors:	Belinda L Sun, Xiaoguang Sun, Nancy Casanova, Alexander N. Garcia, Radu Oita, Amit M. Algotar, Sara M. Camp, Vivian Reyes Hernon, Taylor Gregory, Anne E. Cress, Joe G.N. Garcia
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	EBioMedicine
Subjects:	Nicotinamide phosphoribosyltransferase eNAMPT Prostate cancer Tumor progression Biomarker Targeted therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396420304357

Similar Items

Circulating eNAMPT as a biomarker in the critically ill: acute pancreatitis, sepsis, trauma, and acute respiratory distress syndrome
by: Christian Bime, et al.
Published: (2022-06-01)

A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression
by: Belinda L. Sun, et al.
Published: (2021-12-01)

eNAMPT/TLR4 inflammatory cascade activation is a key contributor to SLE Lung vasculitis and alveolar hemorrhage
by: Gantsetseg Tumurkhuu, et al.
Published: (2023-01-01)

eNAMPT Neutralization Preserves Lung Fluid Balance and Reduces Acute Renal Injury in Porcine Sepsis/VILI-Induced Inflammatory Lung Injury
by: Saad Sammani, et al.
Published: (2022-06-01)

Extracellular Nicotinamide Phosphoribosyltransferase Is a Component of the Senescence-Associated Secretory Phenotype
by: Chisaka Kuehnemann, et al.
Published: (2022-07-01)

Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker
by: Elise Semerena, et al.
Published: (2023-10-01)

An eNAMPT-neutralizing mAb reduces post-infarct myocardial fibrosis and left ventricular dysfunction
by: Zhonglin Liu, et al.
Published: (2024-01-01)

Differential Expression of Human N-Alpha-Acetyltransferase 40 (hNAA40), Nicotinamide Phosphoribosyltransferase (NAMPT) and Sirtuin-1 (SIRT-1) Pathway in Obesity and T2DM: Modulation by Metformin and Macronutrient Intake
by: Alshahrani A, et al.
Published: (2019-12-01)

NAMPT Inhibition Induces Neuroblastoma Cell Death and Blocks Tumor Growth
by: Frederic A. Vallejo, et al.
Published: (2022-06-01)

The eNAMPT/TLR4 inflammatory cascade drives the severity of intra-amniotic inflammation in pregnancy and predicts infant outcomes
by: Mohamed Ahmed, et al.
Published: (2023-06-01)

Serum Visfatin/NAMPT as a Potential Risk Predictor for Malignancy of Adrenal Tumors
by: Nadia Sawicka-Gutaj, et al.
Published: (2022-09-01)

Ability of metformin to deplete NAD+ contributes to cancer cell susceptibility to metformin cytotoxicity and is dependent on NAMPT expression
by: Yongxian Zhuang, et al.
Published: (2023-07-01)

The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
by: Simone Torretta, et al.
Published: (2020-02-01)

NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion
by: Ying Wu, et al.
Published: (2022-06-01)

Exercise training upregulates intracellular nicotinamide phosphoribosyltransferase expression in humans: a systematic review with meta-analysis
by: Xu Sun, et al.
Published: (2023-10-01)

Potential Therapeutic Effects of NAMPT-Mediated NAD Biosynthesis in Depression In Vivo
by: Jue Wang, et al.
Published: (2022-12-01)

Linkage of NAMPT promoter variants to eNAMPT secretion, plasma eNAMPT levels, and ARDS severity
by: Heather Lynn, et al.
Published: (2023-07-01)

Biosynthesis of Nicotinamide Mononucleotide: Current Metabolic Engineering Strategies, Challenges, and Prospects
by: Shiqi Luo, et al.
Published: (2023-06-01)

Serum nicotinamide phosphoribosyltransferase as a novel biomarker for non-traumatic osteonecrosis of the femoral head
by: Shiying Wang, et al.
Published: (2022-11-01)

Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy
by: Peter M LoCoco, et al.
Published: (2017-11-01)

Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors
by: Sei-ichi Tanuma, et al.
Published: (2020-08-01)

Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer
by: Giorgia Colombo, et al.
Published: (2021-11-01)

Oxidative stress induces cell death partially by decreasing both mRNA and protein levels of nicotinamide phosphoribosyltransferase in differentiated PC12 cells
by: Cuiyan Zhou, et al.
Published: (2021-05-01)

Association of Nicotinamide Phosphoribosyltransferase (NAMPT) Gene Polymorphisms and of Serum NAMPT Levels with Dilated Cardiomyopathy in a Chinese Population
by: Qingyu Dou, et al.
Published: (2015-09-01)

From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
by: Yumeng Zhu, et al.
Published: (2022-07-01)

Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
by: Zahra Bolandghamat Pour, et al.
Published: (2019-11-01)

Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway
by: Duo Feng, et al.
Published: (2020-06-01)

Nicotinamide mononucleotide (NMN) protects bEnd.3 cells against H2O2‐induced damage via NAMPT and the NF‐κB p65 signalling pathway
by: Xiujun Deng, et al.
Published: (2021-03-01)

Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats
by: Geng-Chin Wu, et al.
Published: (2017-04-01)

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
by: Mario Paolo Colombo, et al.
Published: (2023-10-01)

Comparison of visfatin levels in patients with breast cancer and endometrial cancer with healthy individuals: A systematic review and meta‐analysis
by: Hori Ghaneialvar, et al.
Published: (2022-11-01)

eNAMPT Is Localised to Areas of Cartilage Damage in Patients with Hip Osteoarthritis and Promotes Cartilage Catabolism and Inflammation
by: Ashleigh M. Philp, et al.
Published: (2021-06-01)

Review of various NAMPT inhibitors for the treatment of cancer
by: Yichen Wei, et al.
Published: (2022-09-01)

Correction: Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
Published: (2024-01-01)

1341 Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
by: Mario Paolo Colombo, et al.
Published: (2023-11-01)

Colon-Targeted eNAMPT-Specific Peptide Systems for Treatment of DSS-Induced Acute and Chronic Colitis in Mouse
by: Jae-Sung Kim, et al.
Published: (2022-11-01)

Clickable prodrugs bearing potent and hydrolytically cleavable nicotinamide phosphoribosyltransferase inhibitors
by: Sadrerafi K, et al.
Published: (2018-04-01)

Immunohistochemical Analysis of Nicotinamide Phosphoribosyltransferase Expression in Gastric and Esophageal Adenocarcinoma (AEG)
by: Alexander Arnold, et al.
Published: (2022-12-01)

Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies
by: Paulina Biniecka, et al.
Published: (2023-02-01)

Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2
by: Nancy G. Casanova, et al.
Published: (2022-10-01)